Marketplace®

Daily business news and economic stories

Leading through a period of trial

The biotechnology company Amgen produces two drugs for anemia that have earned the company billions of dollars. But new findings could result in strong warnings being placed on the drugs. Amgen CEO Kevin Sharer talked about his company's situation with Kai Ryssdal.

Download

Executive Snapshot

Who: Kevin Sharer, chairman, president, and chief executive officer of Amgen.

Education: Earned bachelor’s and master’s degrees from the U.S. Naval Academy.

What you may not know: Sharer is an avid art collector.

Personal: Sharer lives in Southern California with his wife, Carol, and has five children.

Related Topics

Collections:

Tagged as: